PL Developments Competitors and Similar CompaniesClear all

Alembic Pharmaceuticals's competitors and similar companies include UCB.
Alembic Pharmaceuticals
Alembic Pharmaceuticals
Alembic Pharmaceuticals is a company that develops, manufactures, and markets pharmaceutical products, pharmaceutical substances, and intermediates
UCB
UCB
UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions.
Founding Date
Founding Date
2010
Founding Date
1928
Type
Type
Public
Type
Public
Tags
Locations
Locations
Vadodara, IN HQ
Baska, IN
Mumbai, IN
Namthang, IN
Vadodara, IN
Vadodara, IN
Locations
Brussels, BE HQ
Melbourne, AU
Vienna, AT
Braine L'alleud, BE
Braine L'alleud, BE
Leuven, BE
São Paulo, BR
see more
Employees
Employees
14,858
Employees
9,052

Financial

Revenue (est.)
Revenue (est.)
₹73.4b (FY, 2026)
Revenue (est.)
€7.4b (FY, 2025)
Cost of goods
Cost of goods
₹19.8b (FY, 2026)
Cost of goods
€1.4b (FY, 2025)
Gross profit
Gross profit
₹54.1b (FY, 2026)
Gross profit
€7.2b (FY, 2025)
Net income
Net income
₹6.7b (FY, 2026)
Net income
€1.6b (FY, 2025)
For sources of this data, please see the company profile

View Company Profiles

UCB
HQ
Brussels, BE
Employees
9,052

UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions.

View company